152 related articles for article (PubMed ID: 23118773)
1. Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.
Ruohonen ST; Vähätalo LH; Savontaus E
Int J Pept; 2012; 2012():452524. PubMed ID: 23118773
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
Ailanen L; Ruohonen ST; Vähätalo LH; Tuomainen K; Eerola K; Salomäki-Myftari H; Röyttä M; Laiho A; Ahotupa M; Gylling H; Savontaus E
J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.
Ruohonen ST; Savontaus E; Rinne P; Rosmaninho-Salgado J; Cavadas C; Ruskoaho H; Koulu M; Pesonen U
Neuroendocrinology; 2009; 89(3):351-60. PubMed ID: 19122447
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.
Ruohonen ST; Pesonen U; Moritz N; Kaipio K; Röyttä M; Koulu M; Savontaus E
Diabetes; 2008 Jun; 57(6):1517-25. PubMed ID: 18276767
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor overexpression in mice abrogates sex differences in body weight, visceral fat, and food intake response to a fast and alters levels of feeding regulatory hormones.
Wang L; Goebel-Stengel M; Yuan PQ; Stengel A; Taché Y
Biol Sex Differ; 2017; 8():2. PubMed ID: 28101317
[TBL] [Abstract][Full Text] [Related]
6. Peripherally Administered Y
Ailanen L; Vähätalo LH; Salomäki-Myftari H; Mäkelä S; Orpana W; Ruohonen ST; Savontaus E
Front Pharmacol; 2018; 9():319. PubMed ID: 29674968
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.
Ruohonen ST; Abe K; Kero M; Toukola L; Ruohonen S; Röyttä M; Koulu M; Pesonen U; Zukowska Z; Savontaus E
Peptides; 2009 Apr; 30(4):715-20. PubMed ID: 19135490
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice.
Vähätalo LH; Ruohonen ST; Mäkelä S; Kovalainen M; Huotari A; Mäkelä KA; Määttä JA; Miinalainen I; Gilsbach R; Hein L; Ailanen L; Mattila M; Eerola K; Röyttä M; Ruohonen S; Herzig KH; Savontaus E
Acta Physiol (Oxf); 2015 Apr; 213(4):902-19. PubMed ID: 25482272
[TBL] [Abstract][Full Text] [Related]
9. Metformin normalizes the structural changes in glycogen preceding prediabetes in mice overexpressing neuropeptide Y in noradrenergic neurons.
Ailanen L; Bezborodkina NN; Virtanen L; Ruohonen ST; Malova AV; Okovityi SV; Chistyakova EY; Savontaus E
Pharmacol Res Perspect; 2018 Apr; 6(2):e00389. PubMed ID: 29541475
[TBL] [Abstract][Full Text] [Related]
10. Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.
Vähätalo LH; Ruohonen ST; Mäkelä S; Ailanen L; Penttinen AM; Stormi T; Kauko T; Piscitelli F; Silvestri C; Savontaus E; Di Marzo V
Nutr Diabetes; 2015 Apr; 5(4):e151. PubMed ID: 25915740
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models.
Vähätalo LH; Ruohonen ST; Ailanen L; Savontaus E
Neuropeptides; 2016 Feb; 55():31-7. PubMed ID: 26681068
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity.
Mattila M; Söderström M; Ailanen L; Savontaus E; Savontaus M
Cardiovasc Toxicol; 2020 Jun; 20(3):328-338. PubMed ID: 31811615
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of neuropeptide Y in the dorsomedial hypothalamus reverses high-fat diet-induced obesity and impaired glucose tolerance in rats.
Kim YJ; Bi S
Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(2):R134-42. PubMed ID: 26561644
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model.
Ruohonen ST; Pesonen U; Savontaus E
Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 3):S569-76. PubMed ID: 23565492
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Dietary Fat and Sucrose on Cognitive Functioning in Mice Lacking Insulin Signaling in Neuropeptide Y Neurons.
Mitchell CS; Goodman EK; Tedesco CR; Nguyen K; Zhang L; Herzog H; Begg DP
Front Physiol; 2022; 13():841935. PubMed ID: 35557971
[TBL] [Abstract][Full Text] [Related]
17. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and leptin sensitivity is dependent on diet composition.
van den Heuvel JK; Eggels L; van Rozen AJ; Luijendijk MC; Fliers E; Kalsbeek A; Adan RA; la Fleur SE
J Neuroendocrinol; 2014 Jun; 26(6):377-85. PubMed ID: 24698502
[TBL] [Abstract][Full Text] [Related]
19. Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons.
Zhang L; Lee IC; Enriquez RF; Lau J; Vähätalo LH; Baldock PA; Savontaus E; Herzog H
Mol Metab; 2014 Aug; 3(5):581-91. PubMed ID: 25061562
[TBL] [Abstract][Full Text] [Related]
20. Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice.
Hollopeter G; Erickson JC; Palmiter RD
Int J Obes Relat Metab Disord; 1998 Jun; 22(6):506-12. PubMed ID: 9665670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
